` PKTX (ProtoKinetix Inc) vs S&P 500 Comparison - Alpha Spread

PKTX
vs
S&P 500

Over the past 12 months, PKTX has underperformed S&P 500, delivering a return of -24% compared to the S&P 500's +38% growth.

Stocks Performance
PKTX vs S&P 500

Loading
PKTX
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
PKTX vs S&P 500

Loading
PKTX
S&P 500
Difference
www.alphaspread.com

Performance By Year
PKTX vs S&P 500

Loading
PKTX
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
ProtoKinetix Inc vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

ProtoKinetix Inc
Glance View

Market Cap
2.9m USD
Industry
Biotechnology

Protokinetix, Inc. is a research and development stage biotechnology company, which engages in the scientific medical research of anti-aging glycoproteins. The company is headquartered in Marietta, Ohio. The company went IPO on 2002-01-07. The firm is focused on the scientific medical research of anti-freeze glycoproteins (AFGPs) and anti-aging glycoproteins (AAGPs). The Company’s anti-aging glycopeptide is for the ophthalmology, dermatology, transplant support and biomanufacturing. The firm has not developed a commercially viable product and has not generated any revenue

PKTX Intrinsic Value
2.0E-6 USD
Overvaluation 100%
Intrinsic Value
Price $0.0074
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett